Para-toluenesulfonamide
Term · Oncology and biomedicine · MLC-T-ONC-015829
A low-molecular-weight organic compound with potential antineoplastic activity. Upon intra-tumoral injection, para-toluenesulfonamide increases lysosomal membrane permeabilization (LMP) and the release of cathepsin B. Cytosolic cathepsin B released from lysosomes cleaves and activates proapoptotic B-cell lymphoma 2 (Bcl-2) family member BH3 interacting-domain death agonist (Bid) and poly [ADP-ribose] polymerase 1 (PARP-1), which may induce tumor cell death.
| Identifier | MLC-T-ONC-015829 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | PTS |
| Synonyms | p-toluenesulfonamide |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015829",
"term": "Para-toluenesulfonamide",
"field": "Oncology and biomedicine",
"definition": "A low-molecular-weight organic compound with potential antineoplastic activity. Upon intra-tumoral injection, para-toluenesulfonamide increases lysosomal membrane permeabilization (LMP) and the release of cathepsin B. Cytosolic cathepsin B released from lysosomes cleaves and activates proapoptotic B-cell lymphoma 2 (Bcl-2) family member BH3 interacting-domain death agonist (Bid) and poly [ADP-ribose] polymerase 1 (PARP-1), which may induce tumor cell death.",
"abbreviation": "PTS",
"synonyms": [
"p-toluenesulfonamide"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/para-toluenesulfonamide/"
}
Record 12,661 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.